Investor Type | Firm |
Type of Fund | VC |
Industries | BioTech • FinTech (& Financials services) • HealthTech (& Fitness) • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Pharmaceutical (& Medicine) |
Stages | Seed, Series A, Series B |
Investing | United States • Canada • China • Hong Kong • Israel |
Investment Range | $1,000,000 - $75,000,000 |
Investment Sweet Spot | $4,000,000 |
Assets Under Management | $18,000,000,000 |
OrbiMed is a venture capital firm that invests in the pharmaceutical, life science, digital health, healthcare services, medical devices, biopharmaceuticals, diagnostics, healthcare technology and biotechnology sectors. The firm was founded in 1989 and is headquartered in New York, New York.